TransoPharm USA works in the Sourcing and Management of Active Pharmaceutical Ingredients.
01 1Transo-Pharm USA LLC
02 1Biophore India Pharmaceuticals Pvt Ltd
03 1Nuray Chemicals Private Limited
04 1HRV Global Life Sciences
05 1TAPI Technology & API Services
06 1Fuan Pharmaceutical
07 1H. Lundbeck AS
08 1MSN Laboratories
01 1China
02 1Denmark
03 4India
04 1Israel
05 1U.S.A
01 5Active
02 3Blank
01 2Valid
02 6Blank
01 1218MF10985
02 7Blank
01 1WC-0416
02 7Blank
Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.
GDUFA
DMF Review : Reviewed
Rev. Date : 2018-01-19
Pay. Date : 2017-12-21
DMF Number : 32335
Submission : 2017-12-16
Status : Active
Type : II
Certificate Number : R0-CEP 2019-298 - Rev 02
Issue Date : 2023-05-15
Type : Chemical
Substance Number : 550
Status : Valid
Nuray is an expert in the synthesis of Niche novel APIs, the first to launch Generics, NCEs, Advanced Intermediates // USFDA certified.
GDUFA
DMF Review : Reviewed
Rev. Date : 2017-02-27
Pay. Date : 2016-12-26
DMF Number : 31249
Submission : 2017-01-27
Status : Active
Type : II
Date of Issue : 2024-02-20
Valid Till : 2026-12-06
Written Confirmation Number : WC-0416
Address of the Firm :
NDC Package Code : 58159-039
Start Marketing Date : 2023-11-08
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (35kg/35kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : Reviewed
Rev. Date : 2019-04-12
Pay. Date : 2018-08-17
DMF Number : 32771
Submission : 2018-05-07
Status : Active
Type : II
NDC Package Code : 52952-003
Start Marketing Date : 2012-07-25
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : Reviewed
Rev. Date : 2017-06-02
Pay. Date : 2017-05-01
DMF Number : 7031
Submission : 1987-06-22
Status : Active
Type : II
Registration Number : 218MF10985
Registrant's Address : Via Quarta Strada, 2 Padova Italy
Initial Date of Registration : 2006-12-18
Latest Date of Registration : --
NDC Package Code : 45562-1740
Start Marketing Date : 2022-01-26
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (100kg/100kg)
Marketing Category : DRUG FOR FURTHER PROCESSING
GDUFA
DMF Review : Reviewed
Rev. Date : 2022-01-26
Pay. Date : 2021-12-30
DMF Number : 35351
Submission : 2020-11-28
Status : Active
Type : II
Certificate Number : R0-CEP 2021-065 - Rev 00
Issue Date : 2023-03-03
Type : Chemical
Substance Number : 550
Status : Valid
NDC Package Code : 14501-0096
Start Marketing Date : 2020-02-19
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
A Diazoxide manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Diazoxide, including repackagers and relabelers. The FDA regulates Diazoxide manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Diazoxide API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Diazoxide manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Diazoxide supplier is an individual or a company that provides Diazoxide active pharmaceutical ingredient (API) or Diazoxide finished formulations upon request. The Diazoxide suppliers may include Diazoxide API manufacturers, exporters, distributors and traders.
click here to find a list of Diazoxide suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
We have 8 companies offering Diazoxide
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?